Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...

The U.S. Treasury Department on Friday said it plans to proceed with the sales of Treasury bills and coupons this month as ...

Discover why QDTE's strong dividends may face hidden risks in 0DTE options. Learn key insights and why now may be the time to ...

For 3Q25, Macquarie Natural Resources Fund Institutional Class shares rose, and outperformed the Fund’s benchmark, the S&P ...

Mexican airline carriers Volaris ( VLRS) and Viva Aerobus announced a merger of equals to combine their holding companies ...

Alexander's, Inc. is a commercial REIT managing five properties in New York, with Bloomberg accounting for 60% of revenues.

Discover why Pfizer (PFE) remains a compelling income opportunity with a 7% yield, robust cash flow, and long-term growth ...

Micron Technology surged after a strong earnings beat and bullish guidance. Find out why MU stock is a buy for 2026.

Gold trades near $4,320 after gaining roughly 65% this year. Price remains firmly above rising short- and medium-term moving ...

CoreWeave, Inc. is a strong AI infrastructure buy after record Q3 growth, reduced risk, and major contracts. Click here to ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

Nektar Therapeutics is advancing Rezpeg in atopic dermatitis and alopecia areata. Click here for key insights on NKTR's ...